Open AccessCurrent strategy in the treatment of calcium pyrophosphate crystal deposition disease
Author(s) -
С. А. Владимиров,
М. С. Елисеев
Publication year - 2019
Publication title -
naučno-praktičeskaâ revmatologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.137
H-Index - 9
eISSN - 1995-4492
pISSN - 1995-4484
DOI - 10.14412/1995-4484-2018-746-752
Subject(s) - nonsteroidal , calcium pyrophosphate , colchicine , pyrophosphate , disease , calcium , medicine , pharmacology , drug , deposition (geology) , chemistry , nanotechnology , materials science , biochemistry , biology , paleontology , enzyme , sediment
The paper considers currently available drugs used to treat calcium pyrophosphate crystal deposition disease. It discusses the advantages and disadvantages of the most widely used drugs, such as nonsteroidal anti-inflammatory drugs, colchicine, glucocorticoids, traditional immunosuppressants, as well as prospects for the use of biologic agents.